VirtualScopics Signs Alliance Framework Agreement With IXICO

(RTTNews) - VirtualScopics, Inc. (VSCP), a provider of clinical trial imaging solutions, Friday announced that it has signed an Alliance Framework Agreement and Master Subcontractor Agreement, previously announced as an agreement in principle, with IXICO Pc (IXI.L), which is engaged in researching, diagnosing and treating serious diseases.

The company noted that the alliance will provide the clinical trials industry with global operational capabilities and a full range of therapeutic areas and modality expertise. The alliance enhances both companies' abilities to deliver world-class services to pharmaceutical, biotech and academic customers and collaborators around the globe.

Eric Converse, interim chief executive officer of VirtualScopics, said, "This alliance is a strategic initiative from which both companies will reap significant benefits. The alliance enables us to access IXICO's focus on neurology and gives us a European presence, something that will enhance our ability to serve global pharmaceutical clients."

In London, IXICO shares are currently trading at 57.45 pence, down 3.05 pence or 5.05 percent.

On Nasdaq, VirtualScopics settled at $4.89 on Thursday, down $0.08 or 1.61 percent.